Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.25B
| $41.9M | 0.01% |
1,731,775
+40,459
| +2% | +$969K |
|
927
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
| $41.8M | 0.01% |
1,755,340
-199,841
| -10% | -$4.67M |
|
928
RXO
RXO
$3.46B
| $41.7M | 0.01% |
1,488,928
-20,232
| -1% | -$571K |
|
929
West Pharmaceutical
WST
$24.7B
| $41.6M | 0.01% |
138,628
-117,693
| -46% | -$36M |
|
|
IBDQ
930
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $41.4M | 0.01% |
1,653,743
-50,695
| -3% | -$1.27M |
|
931
Freshpet
FRPT
$3.51B
| $41.3M | 0.01% |
302,019
-92,327
| -23% | -$12.1M |
|
932
Exelixis
EXEL
$14.3B
| $41.3M | 0.01% |
1,590,990
+81,414
| +5% | +$2.02M |
|
933
iShares US Small Cap Equity Factor ETF
SMLF
$4.23B
| $41.1M | 0.01% |
619,968
+312,161
| +101% | +$19.8M |
|
934
Capital One
COF
$136B
| $40.9M | 0.01% |
272,876
-16,826
| -6% | -$2.4M |
|
935
Equifax
EFX
$20.8B
| $40.7M | 0.01% |
138,666
+50,055
| +56% | +$14.1M |
|
936
Kyndryl
KD
$3.07B
| $40.5M | 0.01% |
1,763,028
+18,175
| +1% | +$443K |
|
937
Constellation Energy
CEG
$94.7B
| $40.4M | 0.01% |
155,454
-10,899
| -7% | -$2.17M |
|
938
Live Oak Bancshares
LOB
$2.03B
| $40.4M | 0.01% |
853,028
-168,364
| -16% | -$7.04M |
|
939
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.64B
| $40.4M | 0.01% |
2,061,222
-174,908
| -8% | -$3.4M |
|
|
GAP
940
The Gap Inc
GAP
$7.4B
| $40.3M | 0.01% |
1,826,802
+413,622
| +29% | +$9.19M |
|
941
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
| $40.3M | 0.01% |
866,566
+114,230
| +15% | +$5.21M |
|
942
iShares Silver Trust
SLV
$29.9B
| $40.2M | 0.01% |
1,416,419
+110,635
| +8% | +$2.97M |
|
943
InterDigital
IDCC
$8.53B
| $40.2M | 0.01% |
284,072
-10,872
| -4% | -$1.43M |
|
944
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.42B
| $40.1M | 0.01% |
522,616
-108,023
| -17% | -$7.98M |
|
945
Yum! Brands
YUM
$41.6B
| $40M | 0.01% |
286,461
+8,051
| +3% | +$1.07M |
|
946
Vaxcyte
PCVX
$8.07B
| $40M | 0.01% |
350,151
+72,387
| +26% | +$6.52M |
|
947
Signet Jewelers
SIG
$3.75B
| $39.9M | 0.01% |
387,066
-1,108
| -0.3% | -$93.6K |
|
948
Gates Industrial Corporation Ltd.
GTES
$7.42B
| $39.9M | 0.01% |
2,274,651
+438,418
| +24% | +$7.46M |
|
949
HNI Corp
HNI
$3.51B
| $39.9M | 0.01% |
741,190
-40,602
| -5% | -$2.06M |
|
950
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $39.9M | 0.01% |
1,631,827
-3,315,548
| -67% | -$79.9M |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.